Free Trial

Bioventus (BVS) SEC Filings & 10K Form

Bioventus logo
$7.22 -0.16 (-2.10%)
As of 03:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Bioventus SEC Filings

DateFilerForm TypeView
08/06/2025
6:42 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025
6:45 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2025
7:15 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2025
7:12 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:49 PM
Bartholdson John A. (Reporting)
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
8:22 AM
Bartholdson John A. (Reporting)
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:29 PM
Beyer Pat (Reporting)
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:29 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Cowdy Philip G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:29 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Ladone Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
McMurry-Heath Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
NEELS GUIDO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
NOHRA GUY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
STALNECKER SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
SUTTER MARTIN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
4:10 PM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form SD
Specialized Disclosure Report  
05/06/2025
6:36 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:38 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2025
8:17 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form ARS
04/15/2025
4:49 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
4:50 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
4:50 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:30 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:31 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:39 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
D'Adamio Anthony (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2025
4:37 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:50 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
Singleton Mark Leonard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2025
4:24 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:33 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:34 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
6:05 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
6:06 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:42 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
6:45 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2025
6:40 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
6:00 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:00 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:01 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
4:59 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
5:00 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Biotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B market (Ad)

A small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.

👉 Click here for the full breakdown on This Company and why investors are tuning in now.
02/18/2025
5:00 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:59 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Claypoole Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
8:16 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
Claypoole Robert E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
4:24 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Claypoole Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:54 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:55 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:55 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:34 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
D'Adamio Anthony (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
4:35 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
CHURCH KATRINA J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
4:37 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
Singleton Mark Leonard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
4:27 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:28 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:28 PM
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:53 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
11/08/2024
8:13 PM
Bioventus (Subject)
Bioventus Inc. (Subject)
Spindletop Healthcare Capital, L.P. (Filed by)
Form SC 13G/A
11/05/2024
6:34 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:36 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
11:15 PM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form EFFECT
10/25/2024
3:14 PM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/04/2024
6:45 AM
Bioventus (Filer)
Bioventus Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:16 PM
Bartholdson John A. (Reporting)
Bioventus (Issuer)
Bioventus Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:BVS) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners